Contact Us
Drug Search Results
More Filters [+]

Bromopride

Alternative Names: bromopride
Latest Update: 2023-10-31
Latest Update Note: PubMed Publication

Product Description

Bromopride is a dopamine antagonist used as an antiemetic. Its prokinetic properties are similar to those of metoclopramide. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Bromopride)

Mechanisms of Action: D2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Colombia | Dominican Republic | Ecuador | Germany | Italy | Korea | Peru | Portugal | Taiwan | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: EMS
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bromopride

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Dyspepsia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
BRDEMS1011

P3

Completed

Dyspepsia

2018-03-13

70%

Recent News Events

Date

Type

Title

10/31/2023

PubMed

 Compatibility Assessment of Novel Orodispersible Film Vehicle for Personalized Medicine with Selected Active Pharmaceutical Ingredients.

09/15/2023

PubMed

 Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit.

08/01/2022

PubMed

 Development of novel montmorillonite-based sustained release system for oral bromopride delivery.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions